Nykredit A/S’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,505
Closed -$147K – 1962
2026
Q2
$147K Buy
+1,505
New +$131K ﹤0.01% 1162

Other funds holding DNTH

Nykredit A/S's DNTH Position: Q3 2026 in Review

Nykredit A/S sold out of Dianthus Therapeutics (DNTH) in Q3 2026, closing a stake of 1,505 shares — an estimated $147K sold.

Nykredit A/S first reported a position in DNTH in Q2 2026 and held it in 1 quarter. The position peaked at $147K in Q2 2026. 274 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Nykredit A/S reported no remaining Dianthus Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Nykredit A/S sold 1,505 Dianthus Therapeutics shares in Q3 2026, an estimated $147K.
  • Nykredit A/S first reported a position in Dianthus Therapeutics in Q2 2026 and held it in 1 quarter.
  • Nykredit A/S's Dianthus Therapeutics position peaked at $147K in Q2 2026.
  • 274 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.